ArticleFrontiers in pharmacology2023

LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA

Guoying Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.